VENABLE LLP for GLOBAL ANTIBIOTIC RESEARCH & DEVELOPMENT PARTNERSHIP, NORTH AMERICA (GARDP NA)
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY 23 Labor, Health and Human Services, Education, and State and Foreign Operations appropriations regarding antibiotic research and development; FY 24 funding for antibiotic research and development.
Foreign entity interest: Global Antibiotic Research and Development Partnership (GARDP), listed on the registration, has an interest in the issues disclosed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JODIE CURTIS | — |
| LAURA A HANEN | — |
Medical/Disease Research/Clinical Labs MED
Antibiotic research and development; S. 3799, PREVENT Pandemics Act; H.R. 3932/S. 2076, the PASTEUR Act.
Foreign entity interest: Global Antibiotic Research and Development Partnership (GARDP), listed on the registration, has an interest in the issues disclosed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JODIE CURTIS | — |
| LAURA A HANEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.